Biocon Q2 Results: Biosimilars Power 61% Revenue, US Expansion & New Launches In Pipeline
7:59
YouTubeNDTV Profit
Biocon Q2 Results: Biosimilars Power 61% Revenue, US Expansion & New Launches In Pipeline
Biocon Ltd. reported a profit of Rs 84.5 crore during the second quarter of the financial year 2026, compared to the loss of Rs 16 crore in the year-ago period. The pharma company reported the consolidated top line at Rs 4,296 crore, marking a 19.6% uptick from the revenue of Rs 3,590 crore in the year-ago period, according to an exchange ...
10.8K views1 month ago
Related Products
Biocon 750 Bladder Scanner
Biocon Books
Biocon Caps
#biocon
How Biocon Is Driving Market Expansion
How Biocon Is Driving Market Expansion
YouTube4 months ago
Semaglutide Has A $55 Billion Market Already, Likely To Reach $100 Billion: Ajanta Pharma
Semaglutide Has A $55 Billion Market Already, Likely To Reach $100 Billion: Ajanta Pharma
YouTube2 weeks ago
Top videos
Biocon Anthem: A Tribute by Bioconites to Our Legacy and Unity !
1:28
Biocon Anthem: A Tribute by Bioconites to Our Legacy and Unity !
YouTubeBiocon Limited
4.2K viewsNov 29, 2024
U.S. Launches Drive Growth Momentum
15:26
U.S. Launches Drive Growth Momentum
YouTubeBusiness Today
1.8K views1 month ago
Biocon Merger Deal: Is It a Big Buy or Time to Say Bye? | Anil Singhvi Insights
1:42
Biocon Merger Deal: Is It a Big Buy or Time to Say Bye? | Anil Singhvi Insights
YouTubeZee Business
19.5K views1 month ago
Biocon Biologics
News Par Views | Biocon Biologics Biocon Biologics को Wholly Owned Subsidiary बनाएगी Biocon शेयर स्वैप से Biocon खरीदेगी माइनॉरिटी हिस्सा Biocon Biologics में निवेश करके हिस्सेदारी क्यों खरीद रही Biocon? Biocon Biologics में कितना Stake खरीदेगी Biocon? फंड जुटाने को लेकर क्या है कंपनी की योजना? कंबाइंड एंटिटी में डेट रीपेमेंट को लेकर क्या इरादा? देखिए Biocon Biologics के MD & CEO श्रीहास तांबे से अनिल सिंघवी से खास बातचीत #Biocon #BioconBiologics #StockMarket | Zee Business
12:55
News Par Views | Biocon Biologics Biocon Biologics को Wholly Owned Subsidiary बनाएगी Biocon शेयर स्वैप से Biocon खरीदेगी माइनॉरिटी हिस्सा Biocon Biologics में निवेश करके हिस्सेदारी क्यों खरीद रही Biocon? Biocon Biologics में कितना Stake खरीदेगी Biocon? फंड जुटाने को लेकर क्या है कंपनी की योजना? कंबाइंड एंटिटी में डेट रीपेमेंट को लेकर क्या इरादा? देखिए Biocon Biologics के MD & CEO श्रीहास तांबे से अनिल सिंघवी से खास बातचीत #Biocon #BioconBiologics #StockMarket | Zee Business
FacebookZee Business
417 views1 month ago
Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO
2:07
Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO
CNBC
Aug 13, 2023
Biocon Biologics may reveal details of its likely IPO post integration of the acquired biosimilar business - CNBC TV18
Biocon Biologics may reveal details of its likely IPO post integration of the acquired biosimilar business - CNBC TV18
cnbctv18.com
Sep 7, 2023